BMJ Open (Jan 2022)
Celecoxib versus placebo as an adjunct to treatment-as-usual in children and youth with obsessive–compulsive disorder: protocol for a single-site randomised quadruple-blind phase II study
Abstract
No abstracts available.
BMJ Open (Jan 2022)